QSAR Model for Drug Human Oral Bioavailability. - Journal of

Siegfried S. F. Leung , Jona Mijalkovic , Kenneth Borrelli , and Matthew P. Jacobson. Journal of Chemical Information and Modeling 2012 52 (6), 1621-1...
1 downloads 0 Views 9KB Size
J. Med. Chem. 2000, 43, 4723

Additions and Corrections 2000, Volume 43 Fumitaka Yoshida and John G. Topliss*: QSAR Model for Drug Human Oral Bioavailability. Page 2578. Table 5, footnote e is incorrect. The correct footnote e is as follows: e Weighting is 0.5, where the carbon R to the carbonyl is tertiary, or the carbonyl is attached to a ring with ortho substituents on each side, or the carbonyl can undergo intramolecular hydrogen bonding with a nearby group. Page 2580. In Table 6, under the “structural descriptors” column, the data for entries 96 and 133 is incorrect. The correct data is 7, 13 for both compounds. Under the “drug” column, the names for entries 83 and 107 are misspelled. The correct spellings are 83, propranolol; 107, chlorthalidone. JM000397H 10.1021/jm000397h Published on Web 10/13/2000

4723